Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Current Leases (2022 - 2026)

Biodesix filings provide 5 years of Current Leases readings, the most recent being $1.5 million for Q1 2026.

  • On a quarterly basis, Current Leases rose 32.72% to $1.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 million, a 32.72% increase, with the full-year FY2025 number at $1.4 million, up 89.71% from a year prior.
  • Current Leases hit $1.5 million in Q1 2026 for Biodesix, up from $1.4 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.8 million in Q1 2023 to a low of $252000.0 in Q4 2023.
  • Median Current Leases over the past 5 years was $1.2 million (2025), compared with a mean of $1.1 million.
  • Biggest five-year swings in Current Leases: tumbled 84.56% in 2024 and later soared 310.67% in 2025.
  • Biodesix's Current Leases stood at $1.5 million in 2022, then plummeted by 83.67% to $252000.0 in 2023, then soared by 185.32% to $719000.0 in 2024, then skyrocketed by 89.71% to $1.4 million in 2025, then grew by 6.45% to $1.5 million in 2026.
  • The last three reported values for Current Leases were $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025) per Business Quant data.